AUSTIN, Texas, March 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix Inc. (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on ...

Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company targeting rare diseases, has selected IBN to manage its corporate communications an ...

Broader protection induced by combination of COVID adenovirus vaccine plus CiVax TM compared to 2-shot mRNA vaccination series ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

The following United Nations General Terms and Conditions of Contract are annexed to the UNPD contract documents as appropriate and form an integral part of the contract documents. General ...

© 2016 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information ...

We will tackle bargain contracts (Wednesday), teams that aced free agency (Thursday) and teams that came up short (Friday). Lindsey Thiry, national NFL reporter: The Jaguars signing Murray.

NFL free agency has started to slow down since officially opening on March 12, so it's a good time to take stock of the moves. We asked a bunch of our NFL experts to weigh in with their picks from ...